Objective: The present study evaluates the impact of prosthesis-patient mismatch (PPM) on left ventricular remodelling following aortic valve replacement (AVR) for severe aortic insufficiency. Methods: In this study, 230 patients undergoing aortic valve surgery were divided into two groups depending on whether or not they exhibited PPM. Postoperative left ventricular (LV) dimensions and function were compared to the preoperative status. Results: The incidence of PPM (EOAi 0.85 cm 2 m À2 ) was 22.2%. There was no significant difference in the reduction of mean end-diastolic LV diameter (LVEDD; p = 0.31) or mean end-systolic LV diameter (LVESD; p = 0.79) between the non-PPM and the PPM groups. The LVEDD was reduced in the non-PPM group from 66 AE 9 to 55 AE 9 mm postoperatively ( p < 0.001) while the LVEDD in the PPM group was reduced from 65 AE 9 to 56 AE 10 mm ( p < 0.001). The LVESD was reduced in the non-PPM group from 49 AE 10 to 40 AE 10 mm postoperatively ( p < 0.001) while the LVESD in the PPM group was reduced from 50 AE 11 to 39 AE 10 mm ( p < 0.001). Patients with preoperative LV dysfunction (ejection fraction (EF) <50%) demonstrated a significant improvement in postoperative LVEF in both the non-PPM (36 AE 8% to 44 AE 12%, p < 0.001) and PPM groups (33 AE 7% to 46 AE 11%, p = 0.001) but no significant difference could be demonstrated in the rate of improvement between the two groups ( p = 0.23). Furthermore, no significant difference was found in survival between patients with PPM and those without ( p = 0.23). Conclusions: PPM did not influence left ventricular remodelling or survival following AVR for severe aortic insufficiency. The left ventricular remodelling process was initiated regardless of preoperative LVEF, and the impact of PPM seems to be of little importance. #
Introduction
It has been suggested that aortic valve replacement (AVR) is associated with a higher risk of adverse events and a lower survival rate in cases of prosthesis-patient mismatch (PPM) [1] . PPM occurs when the effective orifice area (EOA) of the implanted prosthetic valve is too small in relation to the patient's body size [1, 2] . It has been demonstrated in some previous studies that PPM is an important factor related to postoperative recovery of cardiac function [3] and left ventricular (LV) mass regression [4] . In addition, PPM has been shown to have a significant impact on both short-and long-term mortality [5] . However, other studies have reported no adverse effects of PPM on LV remodelling or survival [6, 7] .
In addition to the intrinsic properties of the prosthetic valve, specific patient characteristics have been associated with a higher risk of developing PPM. Mismatch is more likely to occur in patients of advanced age, with larger body size and when aortic valve stenosis is the predominant lesion [8] . However, the impact of PPM on LV remodelling in patients with severe aortic valve insufficiency as the predominant lesion has not previously been evaluated. An insufficient aortic valve causes volume and pressure overload on the left ventricle and, in order to compensate, the left ventricle develops hypertrophy and subsequent dilatation. As long as the left ventricle compensates for the increased work load by a sufficient increase in mass and diameter, the LV ejection fraction (LVEF) remains within normal values. When the cardiac reserves begin to diminish, further dilatation of the left ventricle can be observed in combination with a decrease in LVEF, and, eventually, the patient becomes symptomatic. Following AVR for severe aortic insufficiency, the presence of PPM, with its increased transvalvular gradients and residual stenosis, could hypothetically impair the normalisation of LV diameters, the regression of LV hypertrophy and recovery of LVEF. For some patients, as previously demonstrated by Rahimtoola [2] , one valve abnormality (i.e., severe aortic insufficiency) is converted to another with mild-to-moderate LV outflow obstruction following surgery. In the present study, the objective was to evaluate the influence of PPM on LV remodelling and the recovery of LVEF in patients undergoing AVR for severe aortic insufficiency.
Methods

Patient population
Between January 1998 and October 2008, 230 patients underwent AVR due to severe aortic insufficiency at the Department of Cardiothoracic Surgery at the Lund University Hospital. Patients undergoing concomitant coronary artery bypass graft (CABG) were included in the study. Exclusion criteria were patients under 18 years of age, patients receiving homo-or autograft, stentless valves, valve-sparing or root-enlargement procedures, double valve replacement, aortic dissection, surgery on the aortic arch and other procedures, including deep hypothermia with circulatory arrest. Patients with acute endocarditis (defined as ongoing antibiotic treatment at the time of surgery) were included in the study. However, these patients were excluded when evaluating postoperative LV remodelling since the pathophysiology for chronic aortic insufficiency with respect to LV dimensions differs from that of acute endocarditis. Valve pathology was mainly classified as annulo-aortic ectasia with or without aneurysm (n = 70), acute endocarditis (n = 46), degenerative cusp prolapse (n = 40), congenital valve disease (n = 27), repeat AVR including prosthesis endocarditis (n = 17), valve destruction due to previously conservatively treated endocarditis (n = 11) and mixed pathology (n = 19). The native aortic valve was bicuspid in 24% (n = 59), tricuspid in 68% (n = 153) and tetracuspid in 0.4% (n = 1) of the study population. Pre-, intra-and postoperative variables were prospectively collected and recorded into the department's computerised cardiac surgical database. In addition, medical records were retrospectively reviewed, or contact was made with the patient or the patient's physician when necessary. The pre-and intra-operative characteristics of the patient population are summarised in Table 1 . The study protocol was approved by The Ethics Committee for Clinical Research at the Lund University, Sweden.
Prosthesis-patient mismatch
The EOA of each type and size of prosthesis was obtained from the previous publications [8] [9] [10] and averaged if more than one published value was available [3] . Due to insufficient published data for the St Jude Epic Supra (size 27) and Mitroflow Pericardial (size 27) bioprostheses, the EOA was derived from echocardiography in these two patients. The EOA was indexed to the patient's body surface area (BSA), as previously described by Pibarot and Dumesnil [8] . PPM was defined as moderate when EOAi 0.85 cm 2 m À2 and severe when EOAi 0.65 cm 2 m À2 .
Echocardiography
A complete two-dimensional, pulsed Doppler echocardiographic examination was performed using a Philips I33 echocardiograph (Andover, MA, USA) with a 2.5-MHz broadband transducer. Measurements were made as recommended by the European Society of Cardiology [11] and averaged over three cycles in sinus rhythm or over six cycles in atrial fibrillation. Long-and short-axis views were obtained from the parasternal window, and LV inner dimensions were measured at end-diastole (LVEDD) and at end-systole (LVESD) using M-mode echocardiography. LVEDD was defined as the beginning of the Q-wave on the electrocardiogram (ECG). LVESD was measured as the smallest LV dimension during the time interval between the time at peak septal motion and peak anterior movement of the LV posterior wall. If possible, the LV mass was calculated using the formula LV mass = 1.04 [(LVIDd + IVSd + LPWDd) 3 À (LVIDd) 3] À 13.6 and was normalised to the patient's BSA. In cases where the acoustic window was poor, wall thickness was assessed visually and LV hypertrophy categorised as normal, mild, moderate or severe. Regional and global LV systolic function was assessed from the apical two-and four-chamber view. LV systolic function was defined as impaired if there was evidence of global or regional hypokinesia in more than one segment of the left ventricle. The EF was calculated using the modified Simpson's method. The pressure gradients (peak and mean) of the prostheses were calculated from continuous-wave Doppler measurements using the modified Bernoulli equation. Regurgitant jets were localised, and then graded using a combination of the diameter of the base of the jet, the extension of the jet into the left ventricle and the density and slope of the aortic regurgitant signal recorded during continuous-wave Doppler measurements. Postoperative echocardiographic data were available for 80% of the patients at a mean of 1.7 AE 2.1 years (median 0.7; range 0-9.2 years). All patients underwent an early postoperative echocardiographic examination, but 47 patients were not evaluated 1 year postoperatively (5/47 deceased within a month).
Follow-up
Early mortality was defined as all-cause mortality within 30 days of surgery. Valve-and cardiac-related death was classified in accordance with the Guidelines for Reporting Morbidity and Mortality after Cardiac Valvular Operations [12] . Post-discharge survival data and cause of death were obtained from the Swedish National Board of Health and Welfare or, if necessary, from patient records. Follow-up was 100% complete and included 1056 patient-years. The mean follow-up time was 4.2 AE 3.0 years (median 3.7; range 0-10.9 years).
Statistical analysis
Categorical variables were expressed as percentages and continuous variables as means AE 1 standard deviation (SD). The paired-sample t-test was used to compare changes in preoperative and postoperative echocardiographic data (intra-group comparison) and the Student's t-test was used for continuous variables to evaluate differences between patients with and without PPM (comparison between groups). Categorical data were compared using the chi-square test or Fisher's exact test when the expected frequency was less than five. For variables not following a normal distribution, a non-parametric test (Mann-Whitney U-test or Wilcoxon signed-rank test) was used. Survival was analysed in a time-related manner using the Kaplan-Meier method and differences in survival were analysed with the log-rank test. Cox's proportional hazard regression analysis was performed to determine independent predictors of long-term survival. Risk-adjusted survival was assessed with Cox's proportional hazard regression analysis where the inclusion criterion for each outcome was p < 0.200, and the limit for stepwise backward elimination was p < 0.100. Statistical significance was defined as p < 0.05. Statistical analysis was performed with the SPSS statistical software package (SPSS 15.0, Chicago, IL, USA).
Results
Prosthesis-patient mismatch
The overall incidence of PPM (EOAi 0.85 cm 2 m À2 ) was 22.2% (51/230). The incidence of severe PPM (EOAi 0.65 cm 2 m À2 ) was 2.2% (6/230). The results of univariate analysis of pre-and intra-operative data in relation to PPM are presented in Table 1 .
Left ventricular remodelling
The influence of PPM on LV dimensions, LVEF and transprosthetic gradients during follow-up is summarised in Table 2 . A significant postoperative reduction in LVEDD was seen in both the non-PPM group (mean 11 AE 9 mm ( p < 0.001)) and in the PPM group (mean 9 AE 10 mm ( p < 0.001)). No significant difference in mean reduction was found between the two groups ( p = 0.31). LVESD was significantly reduced postoperatively by a mean value of 9 AE 10 mm ( p < 0.001) in the non-PPM group and by a mean value of 8 AE 17 mm ( p < 0.001) in the PPM group. No significant difference in mean LVESD reduction was observed between the non-PPM and the PPM group ( p = 0.79). Neither was any significant difference found in postoperative LVEF recovery between the non-PPM (1 AE 11%) and PPM groups (2 AE 13%) ( p = 0.74). However, when analysing patients with preoperative LVEF <50%, a significant improvement in postoperative LVEF was demonstrated by both the non-PPM (8 AE 11%, 95% confidence interval (CI): 4.5-11, p < 0.001) and the PPM groups (13 AE 7%, 95% CI: 7.0-18, p = 0.001). No significant difference in recovery could be demonstrated between the two groups (95% CI: À3 to À13, p = 0.23). Patients with PPM exhibited a significantly higher peak gradient (33 AE 10 mmHg vs 24 AE 9 mmHg, p < 0.001), but not a significantly higher mean gradient than patients without PPM (17 AE 5 mmHg vs 14 AE 6 mmHg, p = 0.14). No significant difference was seen in the regression of LV hypertrophy in the non-PPM and PPM groups during follow-up ( p = 1.0).
Early mortality and morbidity
The 30-day mortality rate was 2.2% (5/230). Two of the early deaths were mors in tabula. The causes of 30-day mortality were cardiac failure in four patients and renal failure in one patient. Early mortality was not affected by moderate ( p = 0.31) or severe PPM ( p = 1.0). Postoperative renal dysfunction (serum creatinine >200 mmol l À1 ) occurred in 14% (7/50) of the patients with PPM and in 4% (6/178) of the patients without PPM ( p = 0.01). Three of these patients required haemodialysis postoperatively. There was significant association between PPM and a prolonged need for inotropic support (>24 h) (n = 10 (20%) vs n = 17 (10%), p = 0.043).
Late mortality and outcome
The survival rates at 1, 2 and 5 years were 90.2 AE 4.2%, 79.7 AE 5.8% and 71.3 AE 6.9% for the PPM group and 97.2 AE 1.3%, 95.8 AE 1.5% and 89.3 AE 3.0% for the non-PPM group, respectively, p = 0.001 (Fig. 1) . Following adjustment for confounding factors using Cox multivariate analysis, no significant difference in survival could be demonstrated between patients with PPM and those without PPM, p = 0.23.
Independent risk factors for overall mortality evaluated by
Cox regression analysis are given in Table 3 . Implantation of a stented bioprosthesis (hazard ratio (HR): 4.1; 95% CI: 1.75-9.72, p = 0.001), older age (HR: 1.07, 95% CI: 1.02-1.13, p = 0.003) and cardiopulmonary bypass time (HR: 1.01, 95% CI: 1.002-1.011, p = 0.036) were found to be independent predictors of mortality. The overall survival rates for the whole study population at 1, 2 and 5 years were 95.6 AE 1.4%, 92.1 AE 1.8% and 85.1 AE 2.9%, respectively. Four patients demonstrated signs of structural valve deterioration with prosthetic calcification during follow-up. Two of the patients required repeat surgery and explantation during follow-up due to prosthetic endocarditis.
Discussion
The present study suggests that PPM is common in patients with severe aortic insufficiency undergoing AVR, although severe PPM was rare. The presence of PPM did not influence LV remodelling in terms of regression of the LV dimensions postoperatively. Furthermore, there was no difference in postoperative recovery of LV systolic function between patients with and without PPM. Although higher residual transvalvular gradients were observed in patients with PPM, the regression of LV hypertrophy was not significantly impaired. Finally, PPM was found not to be a predictor for increased early and late mortality following AVR for severe aortic insufficiency.
Previous studies have demonstrated that PPM is most likely to occur in patients in whom the predominant lesion was aortic stenosis, as the calcified aortic valve and aortic root present a surgical challenge for the implantation of a prosthetic valve with an adequate EOA [8] . Because aortic insufficiency often presents with annular dilatation and an absence of valve calcification, this condition would intuitively be thought as unrelated to PPM. However, our findings suggest that PPM may occur in up to 22% of the patient population undergoing surgery for severe aortic insufficiency. Although this lesion has been included in the analysis in earlier reports, no previous studies have focussed on the possible influence of PPM on LV remodelling in severe aortic insufficiency [13] .
It has previously been reported that aortic insufficiency with preoperative impairment of LVEF and increased LVESD has a predicted annual mortality of 10-20% in the absence of surgical intervention [14] . It has also been demonstrated that preoperatively impaired LVEF and increased LVEDD are two of the most important determinants of survival and recovery of LV function following surgery [15] [16] [17] . Our findings demonstrate that significant LV remodelling occurs postoperatively in terms of restoration of the LV dimensions, regardless of the presence of PPM. The volume overload on the left ventricle in aortic insufficiency is resolved following AVR, but in the presence of PPM it is replaced by an increase in the transprosthetic gradient [2] . Theoretically, PPM could lead to impaired restoration of LV dimensions as the afterload on the left ventricle and pressure gradient are increased. However, our findings suggest that the transprosthetic gradients do not influence the postoperative LV remodelling negatively, as the recovery rates of LV dimensions were comparable in both groups. On the contrary, our findings suggest that the residual gradient resulting from the prosthesis is more than compensated for by the relief of the excessive work load on the left ventricle through AVR.
The results of this study indicate that the presence of PPM is associated with a significantly higher transprosthetic gradient. This finding is in concordance with previous studies showing residual stenosis to be associated with impaired LV mass regression and poor recovery of LV function [3] . In the present study, no significant impact of PPM could be demonstrated regarding the recovery of LVEF or LVH regression. In patients with poor preoperative LV function (LVEF <50%), the LVEF improved to a greater extent in both the groups, regardless of PPM. This finding is supported by a previous study by Chaliki et al., who demonstrated a significant postoperative improvement in LVEF in patients with aortic insufficiency and poor preoperative LV function [18] . Furthermore, Carroll et al. [19] and Lamb et al. [20] found that the LVEDD and LV volumes in patients with aortic insufficiency became almost normal within 2 weeks of AVR, whereas a significant regression of LVH took at least 6 months. They concluded that complete regression of LVH may take many years [21] . Other studies have shown that patients with severely reduced LVEF and preoperatively dilated LV do not exhibit complete regression of LVH following AVR for aortic insufficiency [17, 18] . Current evidence indicates that regression of LVH is a time-consuming process and, therefore, a longer follow-up time may be required to further elucidate the influence of PPM on LVH regression.
In the present study, the overall survival rates were 96% at 1 year and 85% at 5 years. Our survival outcome is favourable compared to those reported in previous studies where, depending on the degree of LV dysfunction, 1-and 5-year survival rates vary between 81-92% and 68-82%, respectively [17, 22] . The improved survival in the present study could in part be explained by the relatively recent inclusion period. Bhudia et al. demonstrated that survival following AVR improved dramatically across their study time frame for patients with aortic insufficiency and LV dysfunction [17] . In our study, survival was significantly reduced in the presence of PPM according to univariate analysis (Fig. 1) . However, when using multivariate Cox proportional hazard analysis, only age at surgery (HR: 1.07), duration of cardiopulmonary bypass (CPB) (HR: 1.01) and implantation of a bioprostheses (HR: 4.1) had a significant influence on survival. The age limit for choosing a bioprostheses at our institution is around 70 years and therefore these patients naturally have a shorter life expectancy. Previous studies have suggested that inferior haemodynamics and PPM is more likely to occur following implantation of a bioprosthesis compared to a mechanical prosthesis [1] . We performed a sequential multivariate analysis to test our statistical model where bioprosthesis as a variable was excluded. Furthermore, we created a conjugate variable for patients receiving a stented bioprosthesis and PPM. In neither of these sequential steps was PPM found to be a significant predictor for survival. Prolonged CPB has been demonstrated to be strongly associated with impaired survival in previous studies [23] and was supported by our results. CPB is an intra-operative variable and may be a dominant predictor influencing the ability of multivariate test models to assess the impact of PPM. However, following exclusion of CPB, PPM was still not found to be a significant predictor for survival. Mohty et al. reported that severe PPM following surgery for aortic stenosis had a negative effect on late survival in patients younger than 70 years, but not in the elderly population [10] . These results are consistent with those of Moon et al., suggesting that the impact of PPM on postoperative outcome is more pronounced in young patients than in older ones [24] . Younger patients have higher cardiac output requirements and are generally more physically active and, due to their longer life expectancy, they are exposed to the risk of PPM for a longer period of time. In several studies, including the present one, the mean age of patients with aortic insufficiency is lower than that for patients with aortic stenosis [22, 25] . Therefore, patients with aortic insufficiency would theoretically constitute a suitable population for evaluating the impact of PPM on survival. However, in our study, patients with PPM did not show an impaired survival, compared to non-PPM patients, when adjusted for significant risk factors (Table 3) .
The present study has obvious limitations due its nonrandomised design, although patient variables were recorded prospectively in the database. There are differences in baseline patient characteristics for the two groups that may influence outcome. However, by excluding possible confounders (acute endocarditis) and performing sequential multivariate analysis, we improved the ability of our model to test for the influence of PPM. Finally, a larger sample size, as indicated by the breadth of the confidence intervals, might add further information and may be needed for generalisation.
The findings of this study suggest that PPM does not influence LV remodelling or survival following AVR for severe aortic insufficiency. The LV remodelling process was initiated regardless of preoperative LVEF, and the impact of PPM seems to be of little importance. Therefore, in our opinion, the main focus should be on the implantation of a prosthetic valve using a standardised technique without increasing the complexity of the surgical procedure in order to avoid PPM.
